5
Funding Rounds
$263.1m
Money raised
Mammoth Biosciences is an American company based in San Francisco founded on June 1, 2017. Mammoth Biosciences uses CRISPR technology to develop bio-sensing technologies for diagnostics in industries such as healthcare, agriculture, manufacturing, and forensics and genome editing therapeutics.
Industries:
Key people:
- Janice Chen ******@mammoth.bio
- Lucas Harrington *****@mammoth.bio
- Jennifer Doudna ******@berkeley.edu
2
Funding Rounds
$120.0m
Money raised
Scribe Therapeutics develops molecular engineering solutions for CRISPR-based genetic medicine.
Industries:
Key people:
- Benjamin L. Oakes ***@scribetx.com
- Jennifer Doudna ******@berkeley.edu
- Brett T. Staahl *****@scribetx.com
8
Funding Rounds
$117.5m
Money raised
Locus Biosciences is a biotechnology company developing CRISPR-Cas3-engineered precision antibacterial products.
Industries:
Key people:
- Nick Taylor ******@locus-bio.com
- Paul Garofolo ****.********@locus-bio.com
- Charles Gersbach linkedin
10
Funding Rounds
$87.6m
Money raised
Eligo Bioscience is a developer of novel genetic medicines founded in 2014 by Timothy Lu, Xavier Duportet, Luciano Marraffini and David Bikard.
Industries:
Location:
Key people:
- Timothy Lu ***.**@sentibio.com
- Xavier Duportet ******.********@eligo.bio
- Luciano Marraffini
16
Funding Rounds
$328.8m
Money raised
ViaCyte is a biotechnology company using stem cells to create pancreatic beta cell precursors for treating diabetes.
Location:
Key people:
- Paul Laikind **@vrtx.com
6
Funding Rounds
$4.6m
Money raised
Nanomedicine company developing vaccines and therapies with cell-specific targeting.
8
Funding Rounds
$459.7m
Money raised
Silicon Valley-based genetic engineering startup.
Key people:
- Alex Pesch ****.*****@cellares.com
- Paul Dabrowski ****.*********@synthego.com
- Michael Dabrowski *******.*********@synthego.com
9
Funding Rounds
$262.0m
Money raised
A biotechnology company using genetic editing technologies to develop therapies for the treatment of cancer and genetic diseases.
Industries:
Location:
Key people:
4
Funding Rounds
$153.5m
Money raised
Sherlock Biosciences is a Cambridge, Massachusetts-based company founded in 2019 by David R. Walt, Rahul Dhanda, Feng Zhang, Jim Collins, Deborah Hung, Jonathan Gootenberg, Omar Abudayyeh, Pardis Sabeti and Todd Golub.
Industries:
Location:
Key people:
5
Funding Rounds
$425.0m
Money raised
Tmunity Therapeutics is a biotechnology company developing t-cell immunotherapies for the treatment of human diseases.
Industries:
Location:
Key people:
- Dr. Yangbing Zhao linkedin
- Dr. Bruce Levine ******@capstantx.com
- Dr. Carl H. June linkedin
6
Funding Rounds
$41.3m
Money raised
Beta Hatch is an insect protein for farming company founded in 2015 by Virginia Emery.
7
Funding Rounds
$31.4m
Money raised
Oxford Genetics, also known as Oxgene, is a synthetic biology company specializing in DNA design, protein expression optimization and cell line development technologies and services.
Industries:
Location:
Key people:
13
Funding Rounds
$677.0m
Money raised
A gene editing technology company founded in 2015 and based in Boulder, CO, USA.
5
Funding Rounds
$30.9m
Money raised
Horizon Discovery is a company that offers gene editing, CRO, and diagnostics services
2
Funding Rounds
$100.0m
Money raised
Snipr Biome is a synthetic biology company using CRISPR to make products for the microbiome.
Industries:
Location:
Key people:
- Christian Groendahl **@sniprbiome.com
- Morten O. A. Sommer linkedin
- Jasper Clube **@sniprbiome.com
3
Funding Rounds
$600.0k
Money raised
Caspr Biotech is developing a CRISPR-based platform for rapid diagnostic systems for viruses, bacteria and genetic mutations
Industries:
Location:
Key people:
2
Funding Rounds
$110.0m
Money raised
Kyverna is a cell therapy company engineering a new class of curative living medicines for inflammatory and autoimmune diseases.
Location:
Key people:
- Jeffrey Greve *******.*****@ensocell.com
2
Funding Rounds
$33.9m
Money raised
Refuge Biotechnologies is a biotechnology company that uses CRISPR and cell therapy technologies for treating cancer.
Industries:
Location:
Key people:
- Bing C Wang ****.****@refugebiotech.com
- Stanley Qi ***@stanford.edu
11
Funding Rounds
$67.4m
Money raised
Recombinetics is a biotechnology company that uses gene editing for agriculture and medicine
Industries:
Location:
Key people:
- Joe Tector linkedin
- Perry Hackett *****.*******@recombinetics.com
- Scott Fahrenkrug
3
Funding Rounds
$200.0m
Money raised
PACT Pharma is synthesizing neo-epitope targeted T cells and producing a personalized adoptive cell therapy designed to benefit each cancer patient.
3
Funding Rounds
$70.8m
Money raised
Excision BioTherapeutics is a company founded in 2015 and headquartered in Philadelphia.
Industries:
Key people:
- Thomas Malcolm ********@excisionbio.com
- Rob Simmons linkedin
3
Funding Rounds
$3.5m
Money raised
enEvolv is a Medford, Massachusetts-based biological product manufacturer.
Industries:
Key people:
- Jay Konieczka *.*********@enevolv.com
- Farren Isaacs
- George Church ******.******@dyno-tx.com
1
Funding Rounds
$215.0m
Money raised
Arbor Technologies is a company in Cambridge, MA, focusing on biodiscovery using machine learning, genome sequencing, gene synthesis and high-throughput screening.
Industries:
Location:
2
Funding Rounds
$5.2m
Money raised
Agragene develops sterile male insects to replace chemical pesticides for the control of crop pests
Industries:
Key people:
- Omar Akbari
- Ethan Bier
- Valentino Gantz *********.*****@patternbio.com
3
Funding Rounds
$45.5m
Money raised
JumpCode Genomics develops NGS solutions for the oncology, infectious disease, basic research, and consumer genomics fields.
2
Funding Rounds
$115.0m
Money raised
Pairwise uses CRISPR, gene editing and natural diversity in agricultural crops to address global food challenges. The company is working to develop new varieties of crops.
Industries:
Location:
Key people:
- Feng Zhang linkedin
- Haven Baker ******@pairwise.com
- J. Keith Joung *****.*****@sequre-dx.com
3
Funding Rounds
$34.5m
Money raised
GenEdit develops technology for gene editing.
Industries:
Key people:
- Niren Murthy *******@berkeley.edu
- Kunwoo Lee ****@genedit.com
- Hyo Min Park *****@genedit.com
2
Funding Rounds
$156.0m
Money raised
KSQ Therapeutics is a Cambridge, Massachusetts-based company in the pharmaceuticals industry founded in 2015.
Industries:
Location:
Key people:
2
Funding Rounds
$97.5m
Money raised
SparingVision is a retinal Gene Therapy Treatments founded by Jose alain sahel.
Industries:
Location:
Key people:
2
Funding Rounds
$7.4m
Money raised
Blue Heron Biotechnology Inc is company that provides synthetic DNA sequences and related services to the pharmaceutical and biotechnology companies
Industries:
Location:
Key people:
5
Funding Rounds
$298.0m
Money raised
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
Industries:
Location:
4
Funding Rounds
$210.6m
Money raised
Locanabio is a San Diego, California-based biotechnology company developing RNA-targeting gene therapies.
4
Funding Rounds
$38.5m
Money raised
Tropic Biosciences is a genome editing company founded in 2016 by Gilad Gershon.
Industries:
Location:
Key people:
- Eyal Maori ****.*****@tropic.bio
- Gilad Gershon *****.*******@tropic.bio
4
Funding Rounds
$7.8m
Money raised
Canopy Biosciences is a company that aims to increase the commercialization of life science reagent tools and services via in-licensing key technologies.
1
Funding Rounds
Biotech company developing technologies to improve efficiency and safety of CRISPR-Cas gene editing through anti-CRISPR proteins, also known as Acr proteins
Industries:
Key people:
2
Funding Rounds
$5.8m
Money raised
Phytoform Labs is a biotechnology company.
Location:
Key people:
- William Pelton *******.******@phytoformlabs.com
- Nicolas Kral *******.****@phytoformlabs.com
2
Funding Rounds
$695.0m
Money raised
ElevateBio is a company founded by Vikas Sinha, David Hallal and Melissa Carpenter.
Industries:
Key people:
- Melissa Carpenter
- David Hallal *******@elevate.bio
- Vikas Sinha ******@elevate.bio
1
Funding Rounds
$172.0m
Money raised
Wugen is an off-the-shelf Cell Therapies for Cancer founded by Matthew Cooper, Todd Fehniger, Melissa Berrien-Elliott and John DiPersio.
Industries:
Key people:
- Todd Fehniger
- Matthew Cooper *******@wugen.com
- John DiPersio
2
Funding Rounds
$34.0m
Money raised
CureGenetics is a biotechnology company using CRISPR to develop cellular therapies, gene therapies, and molecular diagnostic tools.
3
Funding Rounds
$16.1m
Money raised
Integra Therapeutics is a biotech company engineering the next generation of gene writing tools to cure genetic diseases.
Industries:
Location:
Key people:
2
Funding Rounds
$260.0m
Money raised
Colossal Biosciences is a biotechnology and genetic engineering company that uses gene editing technology to de-extinct species.
Industries:
Location:
1
Funding Rounds
$70.5m
Money raised
Ensoma, Inc. is an in vivo Gene Therapy founded in 2019.
Industries:
Location:
2
Funding Rounds
$60.0m
Money raised
IASO Biotherapeutics is a biopharmaceutical company focused on the development of cell therapies in the field of oncology.
Industries:
Location:
4
Funding Rounds
$89.0m
Money raised
Latch Bio is a San Francisco-based company founded by Kyle Giffin, Kenny Workman and Alfredo Andere.
3
Funding Rounds
$117.5m
Money raised
Spotlight Therapeutics is an in vivo Gene Editing founded in 2017 by Patrick Hsu, Alexander Marson and Jacob Corn.
Industries:
Location:
Key people:
1
Funding Rounds
$40.0m
Money raised
Watchmaker Genomics applies enzymology to enable applications for reading, writing and editing DNA.
Industries:
Location:
Key people:
- Trey Foskett ****.*******@watchmakergenomics.com
- Stephen Picone *******.******@watchmakergenomics.com
- Brian Kudlow *****.******@watchmakergenomics.com
1
Funding Rounds
$1.6m
Money raised
Cultured Decadence is a Wisconsin-based cellular agriculture company using cell culture and tissue engineering technologies to make lobster meat directly from the animal's cells. The company was acquired by Upside Foods in January 2022.
Industries:
Location:
2
Funding Rounds
$315.0m
Money raised
Prime Medicine is a gene Editing Technology founded in 2019 by David R. Liu.
1
Funding Rounds
$14.0m
Money raised
Hui-Gene Therapeutics is a company founded in 2018 by Xuan Yao.
Industries:
Key people:
- Xuan Yao *******@huidagene.com
2
Funding Rounds
$530.0m
Money raised
Tessera Therapeutics is a biotechnology company pioneering Gene Writing™ to drive advancements in genome engineering.
2
Funding Rounds
$175.0m
Money raised
Metagenomi is a Gene-Edited Microbial Treatments.
Location:
2
Funding Rounds
$29.5m
Money raised
ONK Therapeutics is a natural Killer Cell Therapies founded in 2015.
Industries:
Location:
2
Funding Rounds
$35.0m
Money raised
SeQure Dx is a diagnostics company specializing in gene-editing.
Industries:
Location:
Key people:
- J. Keith Joung *****.*****@sequre-dx.com
- Ellen Sheets *****.******@maxcyte.com
- Vikram Pattanayak linkedin
1
Funding Rounds
$45.0m
Money raised
Proof Diagnostics is harnessing CRISPR technology to unlock powerful molecular diagnostics for all, starting with COVID-19 testing.
Industries:
Location:
1
Funding Rounds
$175.0m
Money raised
Affini-T Therapeutics, Inc is a TCR Cell Therapy.
Industries:
Location:
1
Funding Rounds
$87.0m
Money raised
Clade Therapeutics is a stem Cell Therapies founded by Jim Glasheen, Chad Cowan and Leandro Vetcher.
Industries:
Location:
Key people:
2
Funding Rounds
$30.0m
Money raised
Avectas is a Non-Viral Cell Manufacturing Technology.
Industries:
Location:
1
Funding Rounds
$55.0m
Money raised
Epic Bio is a biotechnology company developing ultracompact therapies to modulate gene expression in vivo using the smallest known Cas protein, CasMINI.
Industries:
Location:
1
Funding Rounds
$50.0m
Money raised
iECURE is a gene Editing Therapies.
Industries:
Location:
1
Funding Rounds
$140.0m
Money raised
Industries:
Location:
1
Funding Rounds
$80.0m
Money raised
Industries:
1
Funding Rounds
$4.0m
Money raised
CRISPRQC INC. is a quality Control for CRISPR founded in 2021.